Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy Millions of women with breast cancer could be spared chemotherapy with a groundbreaking genomic test, according to the results of a trial that could transform healthcare guidelines worldwide.Treatment for breast cancer, the world’s most prevalent form of the disease, involves surgery to remove tumours. Ch...